-
Q&A
Elevating AwarenessCate Edwards honors her mother, Elizabeth Edwards, who died in 2010, by campaigning for more metastatic breast cancer resources.
by Susan FitzGerald
-
Get Involved
Planting Hope for PatientsCancer survivor starts organization to make sure cancer patients have thriving gardens.
by Amanda Koehler
-
Editor's Letter
The Promise of ImmunotherapyImmunotherapy is a breakthrough in cancer treatment, but more research is needed to broaden its impact.
by Kevin McLaughlin
-
Forward Look
New Report Finds Crisis in Cancer CareInstitute of Medicine calls for major improvements.
by Stephen Ornes
-
Get Involved
When Cancer Hits HomeNicholas Arquette started an organization to provide support to children who have a parent with cancer.
by Amanda Koehler
-
Editor's Letter
A 50-Year MilestoneEfforts to curb smoking have come a long way, but more work needs to be done.
by Kevin McLaughlin
-
Forward Look
Bane or Boon for Smokers’ Health?FDA weighs regulations for burgeoning e-cigarette market.
by Sharon Reynolds
-
Health Care Reform: What Does It Mean for You?The complex and controversial Affordable Care Act includes reforms that could benefit cancer patients and survivors.
by Bara Vaida
-
Q&A
Pushing Fear AsideLisa Niemi Swayze advocates for research after losing her husband, actor Patrick Swayze, to pancreatic cancer.
by Marci A. Landsmann
-
Forward Look
Truth in AdvertisingSeveral countries explore legality of requiring cigarettes to carry graphic pictures and health warnings.
by Sue Rochman
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
